Geron

NASDAQ GERN
$3.90 0.0000 0.0000%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 18 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

2.35B
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

2.37B
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

1.10
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

603.49M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

84.83 %

Upcoming events Geron

All events
No upcoming events scheduled

Stock chart Geron

Stock analysis Geron

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

-11.69 28.42
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

9.49 4.33
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

-11.32 9.95
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

-0.06 0.65
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

-58.40 7.67

Price change Geron per year

1.20$ 2.36$
Min Max

Summary analysis Geron

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Geron

Revenue and net income Geron

All parameters

Stock news Geron

All news

Geron Taps Michelle Robertson to Succeed Olivia Bloom as Finance Chief

Geron Taps Michelle Robertson to Succeed Olivia Bloom as Finance Chief

Tom Bergeron Says ‘Dancing With The Stars’ Is In ‘Good Hands’ After Tyra Banks Exit

Geron Shares Fall 13% on Public Offering Plans

Geron Shares Fall 13% on Public Offering Plans

Stocks to Watch: Vyant Bio, Geron, Homology Medicines and Personalis

Stocks to Watch: Vyant Bio, Geron, Homology Medicines and Personalis

Geron Shares Fall 9.1% After Hours on Proposed $175M Stock Offering

Geron Shares Fall 9.1% After Hours on Proposed $175M Stock Offering

Geron Shares Rise After Positive Trial Results for Imetelstat

Geron Shares Rise After Positive Trial Results for Imetelstat

Geron Sees Positive Results From Imetelstat Trial

Geron Sees Positive Results From Imetelstat Trial

Boston Bruins Get A Boost With Patrice Bergeron, David Krejci Set To Return

Assaults on the ‘gerontocracy’ reek of ageism — creativity and inventiveness don’t fade with birthdays

Geron started at buy with $4 stock price target at B. Riley

Peter Thiel calls Warren Buffett, Jamie Dimon, and Larry Fink a ‘finance gerontocracy’ and ‘enemies of bitcoin’

Peter Thiel calls Warren Buffett, Jamie Dimon, and Larry Fink a ‘finance gerontocracy’ and ‘enemies of bitcoin’

Geron Corp. Shares Fall Premarket After Public Offering >GERN

Geron Corp. Shares Fall Premarket After Public Offering >GERN

About company Geron

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for hematologic myeloid malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.
Address:
919 East Hillsdale Boulevard, Foster City, CA, United States, 94404
Company name: Geron
Issuer ticker: GERN
ISIN: US3741631036
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 1996-06-30
Sector: Healthcare
Industry: Biotechnology
Site: https://www.geron.com

On which stock exchange are Geron (GERN) stocks traded?

Geron (GERN) stocks are traded on NASDAQ.

What is the ticker of Geron stocks (GERN)?

The stock ticker of Geron’s stocks or in other words, the code is GERN. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Geron (GERN) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Geron (GERN) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Geron (GERN) stocks traded?

Geron (GERN) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Geron (GERN) stocks today?

The current price of Geron stocks on 17.05.2024 is 3.9 dollars. per share.

What is the dynamics of Geron (GERN) stocks from the beginning of the year?

Geron (GERN) quotes have increased by 82.24% from the beginning of the year up to 3.9 dollars. per 1 stocks.

How much did Geron (GERN) stocks increase in мае 2024?

This month Geron (GERN) quotes have increased by -4.41% to 3.9 dollars. per share.

How much are Geron (GERN) stocks worth?

Today, on October, 17.05.2024 Geron’s (GERN) stocks cost 3.9 dollars..

What is the market capitalization of Geron (GERN)?

Capitalization is the market value of Geron (GERN) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 17.05.2024, the market capitalization of Geron (GERN) is estimated at about 2353624459 dollars.